Table of Contents
What changed
Marlin is a listed investment company, so "Revenue" here is investment income and fair-value movements rather than trading sales. On the like-for-like half, total income fell 17.2% to $9.4m, PBT fell 19.4% to $7.5m, and NPAT fell 19.9% to $6.5m. Net operating cash inflow declined more modestly, down 14.7% to $7.2m. The interim dividend was cut 8.3% to 1.88cps.
The balance sheet tightened. Cash fell 45.3% to $5.2m from $9.5m, total liabilities collapsed 74.2% to $1.6m from $6.2m, and total equity eased 5.1% to $213.3m. Total assets stepped down to $214.9m from $230.9m.
What matters
- Income has normalised off an unusually strong HY25. HY25 NPAT of $8.1m was followed by a full-year FY25 NPAT of just $0.3m, implying a loss-making second half of roughly $7.7m. HY26 at $6.5m is down against the HY25 peak but is materially ahead of that H2 FY25 reversal, which is the more important context for portfolio performance.
- Payout cover has tightened. The payout ratio against NPAT rose to 65.3% from 55.1%, even after the 8.3% DPS cut. For an LIC whose earnings are largely mark-to-market, that is a meaningful increase in reliance on current-period investment gains to fund the distribution.
- Cash buffer has been drawn down. Cash on hand halved to $5.2m, while liabilities also stepped down sharply. Without disclosure of borrowings or a net-debt line, it is not possible to tell how much of the cash decline reflects liability repayment versus distributions or reinvestment into the portfolio.
Expectations
No stated targets, forward-work metrics, or formal guidance were provided in the excerpts. FY25 is not a useful seasonality anchor: HY26 annualised to $18.7m against FY25's full-year revenue of $5.9m, reflecting the negative H2 FY25 valuation result. On that basis the release supports the view that HY26 restored positive investment returns, but does not anchor a full-year expectation because LIC outcomes are driven by market moves in the unreported half.
Quality of result
Because this is an LIC, a large portion of "earnings" is unrealised fair-value movement rather than recurring cash. That said, operating cash inflow at $7.2m actually exceeded NPAT of $6.5m, suggesting a reasonable cash component of the result this half — though that conversion is a function of portfolio turnover and dividend receipts rather than operating discipline in a trading sense. The effective tax rate was steady at 13.3% (prior 12.7%) so NPAT is not being flattered by a tax swing; PBT growth of -19.4% and NPAT growth of -19.9% tell the same story. The durability of the result depends on market levels at balance date, not on an identifiable one-off.
Unresolved
- The release excerpts do not disclose the split between realised investment gains, unrealised fair-value movements, and dividend/interest income, which is the central durability question for an LIC.
- Gross borrowings and net debt are not disclosed, so the sharp fall in liabilities and cash cannot be reconciled to repayments versus distributions.
- NTA per share, portfolio concentration, and any performance fee accrual are not in the supplied material, so valuation against NTA and fee leakage cannot be assessed.
- The rationale for the 8.3% DPS cut against a payout ratio that still rose to 65.3% is not explained in the excerpts.
This briefing cannot assess underlying portfolio performance, benchmark-relative returns, or discount-to-NTA dynamics from the disclosures provided.
Key metrics
| Metric | HY26 | HY25 | Change |
|---|---|---|---|
| Revenue | $9.4b | $11.3b | -17.2% ↓ |
| Net profit after tax | $6.5b | $8.1b | -20.0% ↓ |
| Net cash inflow from operating activities | $7.2b | $8.4b | -14.7% ↓ |
| Interim dividend per share | 1.9c | 2.1c | -8.3% ↓ |
| Profit before tax | $7.5b | $9.3b | -19.4% ↓ |
| Cash and cash equivalents | $5.2b | $9.5b | -45.3% ↓ |
| Total assets | $214.9m | $230.9m | -6.9% ↓ |
Analytical metrics
| Metric | HY26 | HY25 | Context |
|---|---|---|---|
| PBT growth | -19.4% | — | — |
| Effective tax rate | 13.3% | 12.7% | — |
| Payout ratio vs NPAT | 65.3% | — | — |
| HY26 share of FY25 revenue | 159.1% | — | Other half was -59.1% |
| HY26 share of FY25 NPAT | n/m | — | Other half was n/m |
| Profit from continuing operations | $6.5b | — | — |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.